MedKoo Cat#: 573607 | Name: EDDA
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ethylenediaminediacetic acid (EDDA) is a derivative of two molecules of glycine wherein the amines are linked.

Chemical Structure

EDDA
EDDA
CAS#5657-17-0

Theoretical Analysis

MedKoo Cat#: 573607

Name: EDDA

CAS#: 5657-17-0

Chemical Formula: C6H12N2O4

Exact Mass: 176.0797

Molecular Weight: 176.17

Elemental Analysis: C, 40.91; H, 6.87; N, 15.90; O, 36.33

Price and Availability

Size Price Availability Quantity
5g USD 350.00 2 Weeks
25g USD 750.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
EDDA, Ethylenediaminediacetic acid, N,N′-Ethylenediglycine
IUPAC/Chemical Name
Ethylenediamine-N,N'-di(acetic acid)
InChi Key
IFQUWYZCAGRUJN-UHFFFAOYSA-N
InChi Code
1S/C6H12N2O4/c9-5(10)3-7-1-2-8-4-6(11)12/h7-8H,1-4H2,(H,9,10)(H,11,12)
SMILES Code
O=C(O)CNCCNCC(=O)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 176.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ahmadpour S, Noaparast Z, Abedi SM, Hosseinimehr SJ. (99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging. J Biomed Sci. 2018 Feb 19;25(1):17. doi: 10.1186/s12929-018-0420-x. PubMed PMID: 29455647; PubMed Central PMCID: PMC5817723. 2: Kazemi Z, Zahmatkesh MH, Abedi SM, Hosseinimehr SJ. Biological Evaluation of 99mTc-HYNIC-EDDA/tricine-(Ser)-D4 Peptide for Tumor Targeting. Curr Radiopharm. 2017 Aug 24;10(2):123-130. doi: 10.2174/1874471010666170519165430. PubMed PMID: 28530534. 3: Garai I, Barna S, Nagy G, Forgacs A. Limitations and pitfalls of 99mTc-EDDA/HYNIC-TOC (Tektrotyd) scintigraphy. Nucl Med Rev Cent East Eur. 2016;19(2):93-8. doi: 10.5603/NMR.2016.0019. Review. PubMed PMID: 27479887. 4: Trogrlic M, Tezak S. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors. Nucl Med Rev Cent East Eur. 2016;19(2):74-80. doi: 10.5603/NMR.2016.0016. PubMed PMID: 27479884. 5: Koçyiğit Deveci E, Ocak M, Bozkurt MF, Türker S, Kabasakal L, Uğur O. The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours. Mol Imaging Radionucl Ther. 2013 Dec;22(3):76-84. doi: 10.4274/Mirt.68552. Epub 2013 Dec 10. PubMed PMID: 24416622; PubMed Central PMCID: PMC3888016.